Eli Lilly & Co. vs. Prestige Consumer Healthcare Inc.
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| LLY | PBH | |
|---|---|---|
| Market Cap | $1.09 trillion | $2.48 billion |
| Revenue (TTM) | — | $1.10 billion |
| Net Income (TTM) | — | $172.01 million |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | PBH | |
|---|---|---|
| P/E Ratio | — | 14.39 |
| Price / Book | — | 1.29 |
| Price / Sales | — | 2.24 |
LLY and PBH split the valuation factors evenly.
Profitability
| LLY | PBH | |
|---|---|---|
| Net Margin | — | 15.57% |
| Return on Equity | — | 8.97% |
LLY and PBH split the profitability factors evenly.
Risk & Sentiment
| LLY | PBH | |
|---|---|---|
| Short Interest | 1.29% | 14.86% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, PBH overview, PBH financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.